Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
J Endocrinol Invest ; 16(1): 61-4, 1993 Jan.
Article in English | MEDLINE | ID: mdl-8445157

ABSTRACT

A 72-year-old man developed bilateral adrenal hemorrhage causing primary adrenal failure three days after total hip replacement, and was found to have coagulation factor XI deficiency. Factor XI deficiency usually causes mild bleeding which is not predictable on the basis of assayable factor XI levels. There have been no previous reports of bilateral adrenal hemorrhage in factor XI deficiency or other inherited coagulation factor deficiencies. We suggest that the risk of bilateral adrenal hemorrhage should be considered in any preoperative evaluation of patients with factor XI deficiency.


Subject(s)
Adrenal Gland Diseases/etiology , Factor XI Deficiency/complications , Hemorrhage/etiology , Aged , Hip Prosthesis , Humans , Male
2.
3.
Med J Aust ; 1(10): 419-20, 1982 May 15.
Article in English | MEDLINE | ID: mdl-7048037

ABSTRACT

To compare the effect of fentanyl, a short-acting narcotic analgesic, with that of diazepam as intravenous premedication for endoscopy of the upper gastrointestinal tract, we allocated at random 200 consecutive outpatients requiring elective endoscopy to receive either fentanyl or diazepam; the procedure was evaluated both by the endoscopist and by the patient. The endoscopists' opinion of the ease of the procedure was significantly better for the group of patients who received fentanyl than for the group who received diazepam (P less than 0.001). The patients' opinion of the procedure was not influenced by the premedication used. No serious side effects were observed in either patient group. We concluded that fentanyl has significant advantages over diazepam as premedication for endoscopy of the upper gastrointestinal tract.


Subject(s)
Diazepam/therapeutic use , Digestive System , Endoscopy , Fentanyl/therapeutic use , Premedication , Aged , Clinical Trials as Topic , Endoscopy/adverse effects , Gastroscopy , Humans , Surveys and Questionnaires
4.
Gut ; 21(7): 574-9, 1980 Jul.
Article in English | MEDLINE | ID: mdl-7000630

ABSTRACT

Pectin has been shown to minimise the fall in blood glucose seen in patients who are troubled by hypoglycaemia attacks after gastric surgery. We therefore performed 50 g glucose tolerance tests with and without 14.5 g pectin on 11 post-gastric surgery patients. After pectin, the high postprandial levels of glucose, insulin, and enteroglucagon were significantly reduced as was the fall in blood glucose between 90 and 120 minutes. These effects of pectin may reflect slower uptake of glucose from the gastrointestinal tract and provide evidence to support the use of unabsorbable carbohydrate gelling agents in treating hypoglycaemia after gastric surgery.


Subject(s)
Gastrectomy , Hypoglycemia/prevention & control , Pectins/therapeutic use , Postoperative Complications/prevention & control , Adult , Aged , Blood Glucose/metabolism , Female , Food , Gastric Emptying/drug effects , Gastrointestinal Hormones/blood , Glucose Tolerance Test , Humans , Insulin/blood , Male , Middle Aged , Vagotomy
5.
Br Med J ; 2(6154): 1744-6, 1978.
Article in English | MEDLINE | ID: mdl-737474

ABSTRACT

Nine diabetic patients who were receiving various treatments supplemented their normal home diets (two patients) or metabolic ward diets (seven patients) with guar crispbread for five days. Their mean urinary glucose excretion fell significantly by 38% during the last two days. A significant fall in fasting blood glucose concentration of 1.1 +/- 0.4 mmol/1 (19.8 +/- 7.2 mg/100 ml) was seen only in those who took guar after the control period. Over eight weeks' treatment insulin dosage was reduced by 21% in five patients, and home testing showed that glycosuria was reduced by 68% in six patients. Guar crispbread is likely to be a useful adjunct to diabetic treatment irrespective of the type of treatment or insulin dosage used.


Subject(s)
Cellulose/therapeutic use , Diet, Diabetic , Dietary Fiber/therapeutic use , Adult , Aged , Blood Glucose/analysis , Bread , Diabetes Mellitus/urine , Female , Glycosuria , Humans , Male , Middle Aged , Time Factors
7.
Br Med J ; 1(6124): 1392-4, 1978 May 27.
Article in English | MEDLINE | ID: mdl-647304

ABSTRACT

To define the type of dietary fibre of fibre analogue with the greatest potential use in diabetic treatment, groups of four to six volunteers underwent 50-g glucose tolerance tests (GTT) with and without the addition of either guar, pectin, gum tragacanth, methylcellulose, wheat bran, or cholestyramine equivalent to 12 g fibre. The addition of each substance significantly reduced blood glucose concentration at one or more points during the GTT and generally reduced serum insulin concentrations. The greatest flattening of the glucose response was seen with guar, but this effect was abolished when hydrolysed non-viscous guar was used. The reduction in the mean peak rise in blood glucose concentration for each substance correlated positively with its viscosity (r = 0.926; P less than 0.01), as did delay in mouth-to-caecum transit time (r = 0.885; P less than 0.02). Viscous types of dietary fibre are therefore most likely to be therapeutically useful in modifying postprandial hyperglycaemia.


Subject(s)
Cellulose/therapeutic use , Dietary Fiber/therapeutic use , Hyperglycemia/prevention & control , Viscosity , Adult , Blood Glucose/metabolism , Cholestyramine Resin/therapeutic use , Diabetes Mellitus/diet therapy , Eating , Edible Grain , Female , Glucose Tolerance Test , Humans , Insulin/blood , Male , Pectins/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...